Herceptin - For metastatic breast cancer tumors that overexpress the HER2 protein

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 1998年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1046 / 1047
页数：2
相关论文
共 50 条
  • [1] Lapatinib in combination with paclitaxel for the treatment of patients with metastatic breast cancer whose tumors overexpress HER2
    Giordano, Sara B.
    Kaklamani, Virginia
    BREAST CANCER MANAGEMENT, 2013, 2 (06) : 529 - 535
  • [2] Herceptin monotherapy in HER2(+)-recurrent breast cancer
    Eidtmann, H
    ONKOLOGIE, 2002, 25 : 14 - 15
  • [3] Herceptin (R) is active as a single agent in women with metastatic breast cancer overexpressing HER2
    Cobleigh, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S316 - S316
  • [4] Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu
    Safran, H
    Iannitti, D
    Ramanathan, R
    Schwartz, JD
    Steinhoff, M
    Nauman, C
    Hesketh, P
    Rathore, R
    Wolff, R
    Tantravahi, U
    Hughes, M
    Maia, C
    Pasquariello, T
    Goldstein, L
    King, T
    Tsai, JY
    Kennedy, T
    CANCER INVESTIGATION, 2004, 22 (05) : 706 - 712
  • [5] HER2 targeted therapy in breast cancer...beyond Herceptin
    Sumanta Kumar Pal
    Mark Pegram
    Reviews in Endocrine and Metabolic Disorders, 2007, 8 : 269 - 277
  • [6] HER2 targeted therapy in breast cancer...beyond Herceptin
    Pal, Sumanta Kumar
    Pegram, Mark
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2007, 8 (03): : 269 - 277
  • [7] Phase II trial of docetaxel and Herceptin (R) as first- or second-line chemotherapy for women with metastatic breast cancer whose tumours overexpress HER2
    Burris, HA
    Hainesworth, JD
    Albain, K
    Huntington, M
    Greco, FA
    Erland, J
    Hussain, A
    Vogel, CL
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S322 - S322
  • [8] Efficacy of HER2 inhibitors in metastatic breast cancer by discordance in HER2 amplification status between primary and metastatic breast cancer
    Van Raemdonck, E.
    Berteloot, P.
    Laenen, A.
    Han, S.
    Van Nieuwenhuysen, E.
    Salihi, R.
    Concin, N.
    Vergote, I.
    Floris, G.
    Wildiers, H.
    Punie, K.
    Neven, P.
    CANCER RESEARCH, 2019, 79 (04)
  • [9] HER2 overexpressing metastatic breast cancer.
    Spigel D.R.
    Burstein H.J.
    Current Treatment Options in Oncology, 2002, 3 (2) : 163 - 174
  • [10] Somatic mutations of the HER2 in metastatic breast cancer
    Fang, Yi
    Jiang, Yanxia
    Wang, Xin
    Yang, Xue
    Gao, Yinqi
    Wang, Jing
    TUMOR BIOLOGY, 2014, 35 (12) : 11851 - 11854
12345